SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway

SHARPIN emerges higher expression in prostate cancerous tissues than in benign prostate hyperplasia by means of immunohistochemistry in our previous study. In this work, we performed the gain of function assay and find that overexpression of SHARPIN in LNCaP, DU145 and PC-3 cells promoted cell proli...

Full description

Saved in:
Bibliographic Details
Published inMedical oncology (Northwood, London, England) Vol. 32; no. 2; p. 444
Main Authors Li, Jin, Lai, Yiming, Cao, Yi, Du, Tao, Zeng, Lexiang, Wang, Ganping, Chen, Xianju, Chen, Jieqing, Yu, Yongsheng, Zhang, Simin, Zhang, Yiming, Huang, Hai, Guo, Zhenghui
Format Journal Article
LanguageEnglish
Published Boston Springer US 01.02.2015
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:SHARPIN emerges higher expression in prostate cancerous tissues than in benign prostate hyperplasia by means of immunohistochemistry in our previous study. In this work, we performed the gain of function assay and find that overexpression of SHARPIN in LNCaP, DU145 and PC-3 cells promoted cell proliferation, invasiveness and reduced apoptosis. Furthermore, SHARPIN overexpression displayed elevated Bcl-2 and Survivin expression and reduced levels of Bax, cleaved caspase-3. Meanwhile, entropic expression of SHARPIN increased the levels of phosphorylated p65, IkBα, ERK and Akt, were selectively increased in these cells. Collectively, our study unraveled the ability of SHARPIN overexpression to induce tumorigenesis of prostate cancer cells through the NF-kB/ERK/Akt pathway and transformation of apoptosis-associated proteins.
ISSN:1357-0560
1559-131X
DOI:10.1007/s12032-014-0444-3